Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1602 results

Durability and Clinical Outcomes of Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses (CoreValve US Expanded Use Study)

31 Dec 2019

Valve-in-valve transcatheter aortic valve implantation (VIV TAVI) over the last few years has been regarded as a reasonable treatment option for patients with failed surgical bioprostheses who are at increased risk for surgical reoperation and suitable anatomical features. While VIV TAVI showed good short-term hemodynamic and...

Dejan Milasinovic

Reviewer

Dejan Milasinovic
M. Pighi

Reviewer

Michele Pighi
Durability and Clinical Outcomes of Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses

Left Ventricular Rapid Pacing Via the Valve Delivery Guidewire in Transcatheter Aortic Valve Replacement (EASY TAVI)

23 Dec 2019

This study reports the results of using the Left ventricular (LV) guidewire for pacing instead of introducing a temporary RV pacing wire. The safety of this approach is weighed against the potential complications of temporary pacing wires that include access and right ventricular perforation.

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Ki Park

Reviewer

Ki Park
Left Ventricular Rapid Pacing Via the Valve Delivery Guidewire in TAVR

Determining the predominant lesion in patients with severe aortic stenosis and coronary stenoses: A multicenter study using intracoronary pressure and flow

20 Dec 2019

Concomitant coronary artery disease (CAD) is frequently found in patients with severe aortic stenosis (AS) undergoing treatment with transcatheter aortic valve implantation (TAVI).

Nicola Ryan

Reviewer

Nicola Ryan
Determining the predominant lesion in patients with severe aortic stenosis and coronary stenoses

Shaping the future of transcatheter valve interventions

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this sesson to discover the future perspectives and innovations on transcatheter valve interventions, and learn of a new therapy in high surgical risk patients with the Tendyne clinical programme, which eliminates mitral regurgitation.

Shaping the future of transcatheter valve interventions

Interactive Case Corner 9 - Complex TAVI & PCI

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to discover a selection of complex PCI and TAVI cases, such as TAVR in low-lying coronary ostium and narrow sinus of valsalva, complex left main primary PCI for a patient with cardiogenic shock, renal disease with bilateral critical renal artery stenosis, and more!

Interactive Case Corner 9 - Complex TAVI & PCI

Updates in TAVI therapies

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn more about the latest updates in TAVI therapies, and discover the unique features of Acurate neo and Lotus Edge, the clinical evidence of both Boston Scientific TAVI platforms, while learning all about the needs of cerebral protection during TAVI procedures.

Updates in TAVI therapies

Early surgery or conservative care for asymptomatic aortic stenosis (RECOVERY)

13 Dec 2019

The RECOVERY trial sought to compare long-term clinical outcomes of early surgical AVR with conservative care strategy according to the current guidelines in asymptomatic patients with very severe AS.

Reviewer

Salvatore Brugaletta

Reviewer

Ali Nazmi Calik
RECOVERY: Early surgery or conservative care for asymptomatic aortic stenosis

A controlled trial of rivaroxaban after transcatheter aortic-valve replacement (GALILEO)

13 Dec 2019

The GALILEO trial was a randomized, open-label, event-driven, international, multicentre trial comparing two different preventive strategies for thromboembolic complications in patients who underwent successful TAVI and had not established indication for oral anticoagulation.

Daniele Giacoppo

Reviewer

Daniele Giacoppo
Eduardo Bahena-López

Reviewer

Eduardo Bahena-López
A controlled trial of rivaroxaban after transcatheter aortic-valve replacement

TAVI and Coronary access

11 Dec 2019

Watch the video on demand with Lars Sondergaard, Giuseppe Tarantini and Thierry Lefevre

PCR Webinar Round Table on TAVI and Coronary access

Outcomes of transcatheter aortic valve replacement in mixed aortic valve disease

06 Dec 2019

This study compared the outcomes of TAVR in patients with pure Aortic Stenosis (i.e., without or trivial AR) vs. patients with MAVD (AS associated with mild to moderate or severe AR).

Babu Ezhumalai

Reviewer

Babu Ezhumalai

Reviewer

Salvatore Brugaletta
Outcomes of transcatheter aortic valve replacement in mixed aortic valve disease

Health status after transcatheter vs. surgical aortic valve replacement in low-risk patients with aortic stenosis

05 Dec 2019

Although multiple studies have demonstrated an early health status benefit with TAVI vs. SAVR , this is the first randomized trial to demonstrate a persistent, albeit modest, health status advantage with TAVI at 6 and 12 months—timepoints at which patients are assumed to have recovered fully...

Reviewer

Salvatore Brugaletta
Health status after transcatheter vs. surgical aortic valve replacement in low-risk patients with aortic stenosis

Prosthesis-patient mismatch following transcatheter aortic valve replacement with supra-annular and intra-annular prostheses

03 Dec 2019

The results of this study suggest that the use of self-expandable valves could help reduce the incidence of post-procedural PPM after TAVI, especially in the population with large body size...

Reviewer

Romain Didier
Souheib Feliachi

Reviewer

Souheib Feliachi
Prosthesis-patient mismatch following TAVR with supra-annular and intra-annular prostheses

Reduced leaflet motion after transcatheter aortic-valve replacement

27 Nov 2019

The GALILEO-4D was a dedicated substudy that sought to evaluate the effect of oral anticoagulation with rivaroxaban on bioprosthetic aortic valve leaflet thickening and motion impairment.

Daniele Giacoppo

Reviewer

Daniele Giacoppo
Antonio H. Frangieh

Reviewer

Antonio H. Frangieh
Reduced leaflet motion after transcatheter aortic-valve replacement

Femoral versus nonfemoral peripheral access for transcatheter aortic valve replacement

05 Dec 2019

Using the data from the national prospective French registry (FRANCE TAVI), this study compared the characteristics and outcomes of TAVR procedures according to whether they were performed through a femoral or a nonfemoral peripheral access.

Reviewer

Salvatore Brugaletta
Femoral vs nonfemoral peripheral access for transcatheter aortic valve replacement

TAVI in bicuspid aortic valve disease

26 Nov 2019

Watch the video on demand with leading experts Bernard Prendergast, Markus Kasel and Won-Keun Kim

View the replay of this PCR Webinar on TAVI in bicuspid aortic valve disease

Impella vs. balloon pump, COLCOT, RECOVERY… reported from AHA 2019 in Philadelphia

19 Nov 2019

Mirvat Al Asnag and Francesco Costa present a brief overview of Impella vs. balloon pump, COLCOT, and RECOVERY trials presented at the AHA 2019 in Philadelphia...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Francesco Costa

Author

Francesco Costa
Impella vs. balloon pump, COLCOT, RECOVERY… reported from AHA 2019 in Philadelphia

Treatment of aortic stenosis for today - Important considerations for the future

Consult this session to learn more about some important considerations when selecting your TAVI device, how innovations drive improvement in procedural and clinical outcomes, and discover various procedural techniques using the latest generation TAVI system, such as Portico IDE FlexNav, NAVITOR next-gen self-expanding valve, and more!

Treatment of aortic stenosis for today - Important considerations for the future

Case-based learning for the Heart Valve Team: TAVI in pure aortic regurgitation

19 Nov 2019 – From PCR London Valves 2019

Consult this session on TAVI in pure aortic regurgitation to learn more about the anatomy and pathophysiology of aortic regurgitation, the current and emerging surgical treatment options, and the potential role of TAVI in this patient group and how to identify potential candidates for transcatheter intervention.

Case-based learning for the Heart Valve Team: TAVI in pure aortic regurgitation

Complications of surgical and transcatheter valve interventions: the case that taught me most

19 Nov 2019 – From PCR London Valves 2019

Consult this session on the complications of surgical and transcatheter valve interventions to learn tips and tricks from high-volume experienced operators, and to discover techniques for an effective prevention and management of life-threatening complications.

Complications of surgical and transcatheter valve interventions: the case that taught me most

TAV in TAV for an 8-year old degenerating TAVI device - Session with LIVE case

19 Nov 2019 – From PCR London Valves 2019

Watch this session with a LIVE demonstration from St Thomas' Hospital - London, United Kingdom

TAV in TAV for an 8-year